Trial Profile
Prospective study on GnRH analogues for ovarian function in women with gynecologic malignancies receiving chemotherapy [Prospektive Studie zur potentiellen Protektion der Ovarfunktion von Frauen mit gynakologischen Malignomen unter Chemotherapie mittels GnRH-Analoga-Applikation]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2013
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Leuprorelin (Primary)
- Indications Ovarian disorders
- Focus Therapeutic Use
- Acronyms Ovar-Protect
- 11 Jun 2013 Status changed from recruiting to completed.
- 07 Sep 2011 New trial record